Skip to main content

Table 1 Estimated population-level economic burden of liver cancer in China in 2019, overall and by subgroups

From: The population-level economic burden of liver cancer in China, 2019–2030: prevalence-based estimations from a societal perspective

Overall and subgroups

Direct expenditure

Indirect cost

Total economic burden

         

GDPb, %

 

Medical, CNY billion

Non-medical, CNY billion

Sub-total, CNY billion

THEa, %

Disability, CNY billion

Premature death, CNY billion

Sub-total, CNY billion

Total, CNY billion

Chinac

OECDd

Overall

19.7 (US$2.9 billion)

1.9 (US$0.3 billion)

21.6 (US$3.1 billion)

0.366

3.0 (US$0.4 billion)

52.0 (US$7.5 billion)

55.1 (US$8.0 billion)

76.7 (US$11.1 billion)

0.085

0.047

Age at diagnosis, years

          

 < 45

3.0

0.3

3.4

0.057

0.5

23.2

23.7

27.0

0.030

0.017

 45–59

7.8

0.8

8.6

0.145

1.3

23.1

24.3

32.9

0.037

0.020

 ≥ 60

8.8

0.8

9.7

0.163

1.3

5.8

7.1

16.8

0.019

0.010

Gender

          

 Male

15.9

1.6

17.5

0.296

2.5

45.2

47.7

65.2

0.072

0.040

 Female

3.8

0.3

4.1

0.070

0.5

6.9

7.4

11.5

0.013

0.007

Region

          

 East

9.2

0.8

10.0

0.170

1.3

23.9

25.3

35.3

0.039

0.022

 Central

5.7

0.7

6.4

0.109

1.1

16.4

17.5

23.9

0.027

0.015

 West

4.8

0.4

5.2

0.088

0.6

11.7

12.3

17.5

0.019

0.011

Clinical stage

          

 I

2.5

0.2

2.7

0.046

0.2

7.4

7.6

10.3

0.011

0.006

 II

4.4

0.4

4.7

0.080

0.8

11.8

12.6

17.3

0.019

0.011

 III

9.1

1.0

10.1

0.171

1.5

23.5

25.0

35.1

0.039

0.022

 IV

3.7

0.3

4.1

0.069

0.6

9.3

9.9

14.0

0.016

0.009

Health insurance

          

 UEBMI

8.2

0.8

9.0

0.153

1.3

20.5

21.8

30.8

0.034

0.019

 URBMI

3.6

0.3

3.9

0.067

0.5

9.1

9.6

13.5

0.015

0.008

 NRCMS

7.4

0.7

8.1

0.137

1.2

20.5

21.7

29.8

0.033

0.018

 Commercial insurance

0.1

0.0

0.1

0.001

0.0

0.5

0.5

0.6

0.001

0.000

 Self-pay

0.2

0.0

0.2

0.004

0.0

1.0

1.0

1.2

0.001

0.001

 Others

0.2

0.0

0.2

0.004

0.0

0.5

0.6

0.8

0.001

0.000

Pathological type

          

 Hepatocellular carcinoma

16.6

1.6

18.2

0.308

2.4

43.6

46.0

64.3

0.071

0.039

 Other

3.1

0.3

3.4

0.058

0.6

8.4

9.0

12.5

0.014

0.008

  1. aTotal health expenditure in China, 2019 [25]. bGross domestic product in China, 2019. cGDP  =  CNY90,030.95 billion from China Statistical Year Book 2019 [26]. dGDP = US$23,601.366 billion from OECD (Organization for Economic Co-operation and Development) [20]. UEBMI: urban employee basic medical insurance; URBMI: urban resident basic medical insurance; NRCMS: new rural cooperative medical system